Paris and Romainville, France, June the 4th, 2007 - In a joint statement with its licensee (Cellectis S.A.), the Institut Pasteur today announced that it has been granted a broad European patent (number EP 0 682 112 B1) related to the use of homologous recombination processes in eukaryotes. The patent covers a "Method for Activating Expression, or Improving the Level of Expression of a Gene". As of today, Cellectis counts 65 patents and patents applications.
